 | • レポートコード：QFJ1-6052 • 出版社/出版日：QYResearch / 2021年6月 ※2024年版があります。お問い合わせください。 • レポート形態：英文、PDF、98ページ • 納品方法：Eメール（納期：3日） • 産業分類：医薬品 |
| Single User | ￥577,200 (USD3,900) | ▷ お問い合わせ |
| Multi User | ￥865,800 (USD5,850) | ▷ お問い合わせ |
• お支払方法：銀行振込（納品後、ご請求書送付）
レポート概要
| QYResearch社発行の本調査レポートでは、皮膚線維症治療の世界市場（2016年～2027年）を対象に調査し、市場動向、主要企業の市場シェア、種類別市場規模（コルチコステロイド、抗線維化剤、免疫療法薬、その他）、用途別市場規模（病院薬局、小売薬局、その他）、主要地域別市場規模（北米、アメリカ、欧州、アジア、日本、中国、韓国、インド、東南アジア、中南米、中東、アフリカ等）、企業情報などをまとめております。 ・市場概要 ・皮膚線維症治療の市場動向 ・企業の競争状況、市場シェア ・皮膚線維症治療の種類別市場規模と予測2016-2027（コルチコステロイド、抗線維化剤、免疫療法薬、その他） ・皮膚線維症治療の用途別市場規模と予測2016-2027（病院薬局、小売薬局、その他） ・皮膚線維症治療の北米市場規模2016-2027（アメリカ、カナダ） ・皮膚線維症治療の欧州市場規模2016-2027（ドイツ、フランス、イギリス等） ・皮膚線維症治療のアジア市場規模2016-2027（日本、中国、韓国、インド、東南アジア等） ・皮膚線維症治療の中南米市場規模2016-2027（メキシコ、ブラジル） ・皮膚線維症治療の中東・アフリカ市場規模2016-2027（トルコ、サウジアラビア等） ・主要企業情報（Pfizer、Sanofi、F. Hoffmann-La Roche、Boehringer Ingelheim、Jubilant Cadista、Horizon Pharma USA、Bristol-Myers Squibb Company） ・結論 |
It refers to the treatment of skin myelofibrosis by drugs such as corticosteroids, anti-fibrotic drugs, and immunotherapy drugs.
Market Analysis and Insights: Global Treatment of Skin Fibrosis Market
The global Treatment of Skin Fibrosis market size is projected to reach US$ XX million by 2027, from US$ XX million in 2020, at a CAGR of XX% during 2021-2027.
With industry-standard accuracy in analysis and high data integrity, the report makes a brilliant attempt to unveil key opportunities available in the global Treatment of Skin Fibrosis market to help players in achieving a strong market position. Buyers of the report can access verified and reliable market forecasts, including those for the overall size of the global Treatment of Skin Fibrosis market in terms of revenue.
On the whole, the report proves to be an effective tool that players can use to gain a competitive edge over their competitors and ensure lasting success in the global Treatment of Skin Fibrosis market. All of the findings, data, and information provided in the report are validated and revalidated with the help of trustworthy sources. The analysts who have authored the report took a unique and industry-best research and analysis approach for an in-depth study of the global Treatment of Skin Fibrosis market.
Global Treatment of Skin Fibrosis Scope and Market Size
Treatment of Skin Fibrosis market is segmented by company, region (country), by Type, and by Application. Players, stakeholders, and other participants in the global Treatment of Skin Fibrosis market will be able to gain the upper hand as they use the report as a powerful resource. The segmental analysis focuses on revenue and forecast by Type and by Application in terms of revenue and forecast for the period 2016-2027.
Segment by Type
Corticosteroids
Antifibrotic Drugs
Immunotherapy Drugs
Other
Segment by Application
Hospital Pharmacy
Retail Pharmacy
Other
By Region
North America
U.S.
Canada
Europe
Germany
France
U.K.
Italy
Russia
Nordic
Rest of Europe
Asia-Pacific
China
Japan
South Korea
Southeast Asia
India
Australia
Rest of Asia
Latin America
Mexico
Brazil
Rest of Latin America
Middle East & Africa
Turkey
Saudi Arabia
UAE
Rest of MEA
By Company
Pfizer
Sanofi
F. Hoffmann-La Roche
Boehringer Ingelheim
Jubilant Cadista
Horizon Pharma USA
Bristol-Myers Squibb Company
1 Report Overview
1.1 Study Scope
1.2 Market Analysis by Type
1.2.1 Global Treatment of Skin Fibrosis Market Size Growth Rate by Type: 2016 VS 2021 VS 2027
1.2.2 Corticosteroids
1.2.3 Antifibrotic Drugs
1.2.4 Immunotherapy Drugs
1.2.5 Other
1.3 Market by Application
1.3.1 Global Treatment of Skin Fibrosis Market Share by Application: 2016 VS 2021 VS 2027
1.3.2 Hospital Pharmacy
1.3.3 Retail Pharmacy
1.3.4 Other
1.4 Study Objectives
1.5 Years Considered
2 Global Growth Trends
2.1 Global Treatment of Skin Fibrosis Market Perspective (2016-2027)
2.2 Treatment of Skin Fibrosis Growth Trends by Regions
2.2.1 Treatment of Skin Fibrosis Market Size by Regions: 2016 VS 2021 VS 2027
2.2.2 Treatment of Skin Fibrosis Historic Market Share by Regions (2016-2021)
2.2.3 Treatment of Skin Fibrosis Forecasted Market Size by Regions (2022-2027)
2.3 Treatment of Skin Fibrosis Industry Dynamic
2.3.1 Treatment of Skin Fibrosis Market Trends
2.3.2 Treatment of Skin Fibrosis Market Drivers
2.3.3 Treatment of Skin Fibrosis Market Challenges
2.3.4 Treatment of Skin Fibrosis Market Restraints
3 Competition Landscape by Key Players
3.1 Global Top Treatment of Skin Fibrosis Players by Revenue
3.1.1 Global Top Treatment of Skin Fibrosis Players by Revenue (2016-2021)
3.1.2 Global Treatment of Skin Fibrosis Revenue Market Share by Players (2016-2021)
3.2 Global Treatment of Skin Fibrosis Market Share by Company Type (Tier 1, Tier 2 and Tier 3)
3.3 Players Covered: Ranking by Treatment of Skin Fibrosis Revenue
3.4 Global Treatment of Skin Fibrosis Market Concentration Ratio
3.4.1 Global Treatment of Skin Fibrosis Market Concentration Ratio (CR5 and HHI)
3.4.2 Global Top 10 and Top 5 Companies by Treatment of Skin Fibrosis Revenue in 2020
3.5 Treatment of Skin Fibrosis Key Players Head office and Area Served
3.6 Key Players Treatment of Skin Fibrosis Product Solution and Service
3.7 Date of Enter into Treatment of Skin Fibrosis Market
3.8 Mergers & Acquisitions, Expansion Plans
4 Treatment of Skin Fibrosis Breakdown Data by Type
4.1 Global Treatment of Skin Fibrosis Historic Market Size by Type (2016-2021)
4.2 Global Treatment of Skin Fibrosis Forecasted Market Size by Type (2022-2027)
5 Treatment of Skin Fibrosis Breakdown Data by Application
5.1 Global Treatment of Skin Fibrosis Historic Market Size by Application (2016-2021)
5.2 Global Treatment of Skin Fibrosis Forecasted Market Size by Application (2022-2027)
6 North America
6.1 North America Treatment of Skin Fibrosis Market Size (2016-2027)
6.2 North America Treatment of Skin Fibrosis Market Size by Type
6.2.1 North America Treatment of Skin Fibrosis Market Size by Type (2016-2021)
6.2.2 North America Treatment of Skin Fibrosis Market Size by Type (2022-2027)
6.2.3 North America Treatment of Skin Fibrosis Market Size by Type (2016-2027)
6.3 North America Treatment of Skin Fibrosis Market Size by Application
6.3.1 North America Treatment of Skin Fibrosis Market Size by Application (2016-2021)
6.3.2 North America Treatment of Skin Fibrosis Market Size by Application (2022-2027)
6.3.3 North America Treatment of Skin Fibrosis Market Size by Application (2016-2027)
6.4 North America Treatment of Skin Fibrosis Market Size by Country
6.4.1 North America Treatment of Skin Fibrosis Market Size by Country (2016-2021)
6.4.2 North America Treatment of Skin Fibrosis Market Size by Country (2022-2027)
6.4.3 United States
6.4.4 Canada
7 Europe
7.1 Europe Treatment of Skin Fibrosis Market Size (2016-2027)
7.2 Europe Treatment of Skin Fibrosis Market Size by Type
7.2.1 Europe Treatment of Skin Fibrosis Market Size by Type (2016-2021)
7.2.2 Europe Treatment of Skin Fibrosis Market Size by Type (2022-2027)
7.2.3 Europe Treatment of Skin Fibrosis Market Size by Type (2016-2027)
7.3 Europe Treatment of Skin Fibrosis Market Size by Application
7.3.1 Europe Treatment of Skin Fibrosis Market Size by Application (2016-2021)
7.3.2 Europe Treatment of Skin Fibrosis Market Size by Application (2022-2027)
7.3.3 Europe Treatment of Skin Fibrosis Market Size by Application (2016-2027)
7.4 Europe Treatment of Skin Fibrosis Market Size by Country
7.4.1 Europe Treatment of Skin Fibrosis Market Size by Country (2016-2021)
7.4.2 Europe Treatment of Skin Fibrosis Market Size by Country (2022-2027)
7.4.3 Germany
7.4.4 France
7.4.5 U.K.
7.4.6 Italy
7.4.7 Russia
7.4.8 Nordic
8 Asia-Pacific
8.1 Asia-Pacific Treatment of Skin Fibrosis Market Size (2016-2027)
8.2 Asia-Pacific Treatment of Skin Fibrosis Market Size by Type
8.2.1 Asia-Pacific Treatment of Skin Fibrosis Market Size by Type (2016-2021)
8.2.2 Asia-Pacific Treatment of Skin Fibrosis Market Size by Type (2022-2027)
8.2.3 Asia-Pacific Treatment of Skin Fibrosis Market Size by Type (2016-2027)
8.3 Asia-Pacific Treatment of Skin Fibrosis Market Size by Application
8.3.1 Asia-Pacific Treatment of Skin Fibrosis Market Size by Application (2016-2021)
8.3.2 Asia-Pacific Treatment of Skin Fibrosis Market Size by Application (2022-2027)
8.3.3 Asia-Pacific Treatment of Skin Fibrosis Market Size by Application (2016-2027)
8.4 Asia-Pacific Treatment of Skin Fibrosis Market Size by Region
8.4.1 Asia-Pacific Treatment of Skin Fibrosis Market Size by Region (2016-2021)
8.4.2 Asia-Pacific Treatment of Skin Fibrosis Market Size by Region (2022-2027)
8.4.3 China
8.4.4 Japan
8.4.5 South Korea
8.4.6 Southeast Asia
8.4.7 India
8.4.8 Australia
9 Latin America
9.1 Latin America Treatment of Skin Fibrosis Market Size (2016-2027)
9.2 Latin America Treatment of Skin Fibrosis Market Size by Type
9.2.1 Latin America Treatment of Skin Fibrosis Market Size by Type (2016-2021)
9.2.2 Latin America Treatment of Skin Fibrosis Market Size by Type (2022-2027)
9.2.3 Latin America Treatment of Skin Fibrosis Market Size by Type (2016-2027)
9.3 Latin America Treatment of Skin Fibrosis Market Size by Application
9.3.1 Latin America Treatment of Skin Fibrosis Market Size by Application (2016-2021)
9.3.2 Latin America Treatment of Skin Fibrosis Market Size by Application (2022-2027)
9.3.3 Latin America Treatment of Skin Fibrosis Market Size by Application (2016-2027)
9.4 Latin America Treatment of Skin Fibrosis Market Size by Country
9.4.1 Latin America Treatment of Skin Fibrosis Market Size by Country (2016-2021)
9.4.2 Latin America Treatment of Skin Fibrosis Market Size by Country (2022-2027)
9.4.3 Mexico
9.4.4 Brazil
10 Middle East & Africa
10.1 Middle East & Africa Treatment of Skin Fibrosis Market Size (2016-2027)
10.2 Middle East & Africa Treatment of Skin Fibrosis Market Size by Type
10.2.1 Middle East & Africa Treatment of Skin Fibrosis Market Size by Type (2016-2021)
10.2.2 Middle East & Africa Treatment of Skin Fibrosis Market Size by Type (2022-2027)
10.2.3 Middle East & Africa Treatment of Skin Fibrosis Market Size by Type (2016-2027)
10.3 Middle East & Africa Treatment of Skin Fibrosis Market Size by Application
10.3.1 Middle East & Africa Treatment of Skin Fibrosis Market Size by Application (2016-2021)
10.3.2 Middle East & Africa Treatment of Skin Fibrosis Market Size by Application (2022-2027)
10.3.3 Middle East & Africa Treatment of Skin Fibrosis Market Size by Application (2016-2027)
10.4 Middle East & Africa Treatment of Skin Fibrosis Market Size by Country
10.4.1 Middle East & Africa Treatment of Skin Fibrosis Market Size by Country (2016-2021)
10.4.2 Middle East & Africa Treatment of Skin Fibrosis Market Size by Country (2022-2027)
10.4.3 Turkey
10.4.4 Saudi Arabia
10.4.5 UAE
11 Key Players Profiles
11.1 Pfizer
11.1.1 Pfizer Company Details
11.1.2 Pfizer Business Overview
11.1.3 Pfizer Treatment of Skin Fibrosis Introduction
11.1.4 Pfizer Revenue in Treatment of Skin Fibrosis Business (2016-2021)
11.1.5 Pfizer Recent Development
11.2 Sanofi
11.2.1 Sanofi Company Details
11.2.2 Sanofi Business Overview
11.2.3 Sanofi Treatment of Skin Fibrosis Introduction
11.2.4 Sanofi Revenue in Treatment of Skin Fibrosis Business (2016-2021)
11.2.5 Sanofi Recent Development
11.3 F. Hoffmann-La Roche
11.3.1 F. Hoffmann-La Roche Company Details
11.3.2 F. Hoffmann-La Roche Business Overview
11.3.3 F. Hoffmann-La Roche Treatment of Skin Fibrosis Introduction
11.3.4 F. Hoffmann-La Roche Revenue in Treatment of Skin Fibrosis Business (2016-2021)
11.3.5 F. Hoffmann-La Roche Recent Development
11.4 Boehringer Ingelheim
11.4.1 Boehringer Ingelheim Company Details
11.4.2 Boehringer Ingelheim Business Overview
11.4.3 Boehringer Ingelheim Treatment of Skin Fibrosis Introduction
11.4.4 Boehringer Ingelheim Revenue in Treatment of Skin Fibrosis Business (2016-2021)
11.4.5 Boehringer Ingelheim Recent Development
11.5 Jubilant Cadista
11.5.1 Jubilant Cadista Company Details
11.5.2 Jubilant Cadista Business Overview
11.5.3 Jubilant Cadista Treatment of Skin Fibrosis Introduction
11.5.4 Jubilant Cadista Revenue in Treatment of Skin Fibrosis Business (2016-2021)
11.5.5 Jubilant Cadista Recent Development
11.6 Horizon Pharma USA
11.6.1 Horizon Pharma USA Company Details
11.6.2 Horizon Pharma USA Business Overview
11.6.3 Horizon Pharma USA Treatment of Skin Fibrosis Introduction
11.6.4 Horizon Pharma USA Revenue in Treatment of Skin Fibrosis Business (2016-2021)
11.6.5 Horizon Pharma USA Recent Development
11.7 Bristol-Myers Squibb Company
11.7.1 Bristol-Myers Squibb Company Company Details
11.7.2 Bristol-Myers Squibb Company Business Overview
11.7.3 Bristol-Myers Squibb Company Treatment of Skin Fibrosis Introduction
11.7.4 Bristol-Myers Squibb Company Revenue in Treatment of Skin Fibrosis Business (2016-2021)
11.7.5 Bristol-Myers Squibb Company Recent Development
12 Analyst’s Viewpoints/Conclusions
13 Appendix
13.1 Research Methodology
13.1.1 Methodology/Research Approach
13.1.2 Data Source
13.2 Disclaimer
13.3 Author Details
Table 1. Global Treatment of Skin Fibrosis Market Size Growth Rate by Type (US$ Million):2016 VS 2021 VS 2027
Table 2. Key Players of Corticosteroids
Table 3. Key Players of Antifibrotic Drugs
Table 4. Key Players of Immunotherapy Drugs
Table 5. Key Players of Other
Table 6. Global Treatment of Skin Fibrosis Market Size Growth by Application (US$ Million): 2016 VS 2021 VS 2027
Table 7. Global Treatment of Skin Fibrosis Market Size by Regions (US$ Million): 2016 VS 2021 VS 2027
Table 8. Global Treatment of Skin Fibrosis Market Size by Regions (2016-2021) & (US$ Million)
Table 9. Global Treatment of Skin Fibrosis Market Share by Regions (2016-2021)
Table 10. Global Treatment of Skin Fibrosis Forecasted Market Size by Regions (2022-2027) & (US$ Million)
Table 11. Global Treatment of Skin Fibrosis Market Share by Regions (2022-2027)
Table 12. Treatment of Skin Fibrosis Market Trends
Table 13. Treatment of Skin Fibrosis Market Drivers
Table 14. Treatment of Skin Fibrosis Market Challenges
Table 15. Treatment of Skin Fibrosis Market Restraints
Table 16. Global Treatment of Skin Fibrosis Revenue by Players (2016-2021) & (US$ Million)
Table 17. Global Treatment of Skin Fibrosis Market Share by Players (2016-2021)
Table 18. Global Top Treatment of Skin Fibrosis Players by Company Type (Tier 1, Tier 2 and Tier 3) (based on the Revenue in Treatment of Skin Fibrosis as of 2020)
Table 19. Ranking of Global Top Treatment of Skin Fibrosis Companies by Revenue (US$ Million) in 2020
Table 20. Global 5 Largest Players Market Share by Treatment of Skin Fibrosis Revenue (CR5 and HHI) & (2016-2021)
Table 21. Key Players Headquarters and Area Served
Table 22. Key Players Treatment of Skin Fibrosis Product Solution and Service
Table 23. Date of Enter into Treatment of Skin Fibrosis Market
Table 24. Mergers & Acquisitions, Expansion Plans
Table 25. Global Treatment of Skin Fibrosis Market Size by Type (2016-2021) (US$ Million)
Table 26. Global Treatment of Skin Fibrosis Revenue Market Share by Type (2016-2021)
Table 27. Global Treatment of Skin Fibrosis Forecasted Market Size by Type (2022-2027) (US$ Million)
Table 28. Global Treatment of Skin Fibrosis Revenue Market Share by Type (2022-2027) & (US$ Million)
Table 29. Global Treatment of Skin Fibrosis Market Size Share by Application (2016-2021) & (US$ Million)
Table 30. Global Treatment of Skin Fibrosis Revenue Market Share by Application (2016-2021)
Table 31. Global Treatment of Skin Fibrosis Forecasted Market Size by Application (2022-2027) (US$ Million)
Table 32. Global Treatment of Skin Fibrosis Revenue Market Share by Application (2022-2027) & (US$ Million)
Table 33. North America Treatment of Skin Fibrosis Market Size by Type (2016-2021) (US$ Million)
Table 34. North America Treatment of Skin Fibrosis Market Size by Type (2022-2027) & (US$ Million)
Table 35. North America Treatment of Skin Fibrosis Market Size by Application (2016-2021) (US$ Million)
Table 36. North America Treatment of Skin Fibrosis Market Size by Application (2022-2027) & (US$ Million)
Table 37. North America Treatment of Skin Fibrosis Market Size by Country (2016-2021) & (US$ Million)
Table 38. North America Treatment of Skin Fibrosis Market Size by Country (2022-2027) & (US$ Million)
Table 39. Europe Treatment of Skin Fibrosis Market Size by Type (2016-2021) (US$ Million)
Table 40. Europe Treatment of Skin Fibrosis Market Size by Type (2022-2027) & (US$ Million)
Table 41. Europe Treatment of Skin Fibrosis Market Size by Application (2016-2021) (US$ Million)
Table 42. Europe Treatment of Skin Fibrosis Market Size by Application (2022-2027) & (US$ Million)
Table 43. Europe Treatment of Skin Fibrosis Market Size by Country (2016-2021) & (US$ Million)
Table 44. Europe Treatment of Skin Fibrosis Market Size by Country (2022-2027) & (US$ Million)
Table 45. Asia-Pacific Treatment of Skin Fibrosis Market Size by Type (2016-2021) (US$ Million)
Table 46. Asia-Pacific Treatment of Skin Fibrosis Market Size by Type (2022-2027) & (US$ Million)
Table 47. Asia-Pacific Treatment of Skin Fibrosis Market Size by Application (2016-2021) (US$ Million)
Table 48. Asia-Pacific Treatment of Skin Fibrosis Market Size by Application (2022-2027) & (US$ Million)
Table 49. Asia-Pacific Treatment of Skin Fibrosis Market Size by Region (2016-2021) & (US$ Million)
Table 50. Asia-Pacific Treatment of Skin Fibrosis Market Size by Region (2022-2027) & (US$ Million)
Table 51. Latin America Treatment of Skin Fibrosis Market Size by Type (2016-2021) (US$ Million)
Table 52. Latin America Treatment of Skin Fibrosis Market Size by Type (2022-2027) & (US$ Million)
Table 53. Latin America Treatment of Skin Fibrosis Market Size by Application (2016-2021) (US$ Million)
Table 54. Latin America Treatment of Skin Fibrosis Market Size by Application (2022-2027) & (US$ Million)
Table 55. Latin America Treatment of Skin Fibrosis Market Size by Country (2016-2021) & (US$ Million)
Table 56. Latin America Treatment of Skin Fibrosis Market Size by Country (2022-2027) & (US$ Million)
Table 57. Middle East & Africa Treatment of Skin Fibrosis Market Size by Type (2016-2021) (US$ Million)
Table 58. Middle East & Africa Treatment of Skin Fibrosis Market Size by Type (2022-2027) & (US$ Million)
Table 59. Middle East & Africa Treatment of Skin Fibrosis Market Size by Application (2016-2021) (US$ Million)
Table 60. Middle East & Africa Treatment of Skin Fibrosis Market Size by Application (2022-2027) & (US$ Million)
Table 61. Middle East & Africa Treatment of Skin Fibrosis Market Size by Country (2016-2021) & (US$ Million)
Table 62. Middle East & Africa Treatment of Skin Fibrosis Market Size by Country (2022-2027) & (US$ Million)
Table 63. Pfizer Company Details
Table 64. Pfizer Business Overview
Table 65. Pfizer Treatment of Skin Fibrosis Product
Table 66. Pfizer Revenue in Treatment of Skin Fibrosis Business (2016-2021) & (US$ Million)
Table 67. Pfizer Recent Development
Table 68. Sanofi Company Details
Table 69. Sanofi Business Overview
Table 70. Sanofi Treatment of Skin Fibrosis Product
Table 71. Sanofi Revenue in Treatment of Skin Fibrosis Business (2016-2021) & (US$ Million)
Table 72. Sanofi Recent Development
Table 73. F. Hoffmann-La Roche Company Details
Table 74. F. Hoffmann-La Roche Business Overview
Table 75. F. Hoffmann-La Roche Treatment of Skin Fibrosis Product
Table 76. F. Hoffmann-La Roche Revenue in Treatment of Skin Fibrosis Business (2016-2021) & (US$ Million)
Table 77. F. Hoffmann-La Roche Recent Development
Table 78. Boehringer Ingelheim Company Details
Table 79. Boehringer Ingelheim Business Overview
Table 80. Boehringer Ingelheim Treatment of Skin Fibrosis Product
Table 81. Boehringer Ingelheim Revenue in Treatment of Skin Fibrosis Business (2016-2021) & (US$ Million)
Table 82. Boehringer Ingelheim Recent Development
Table 83. Jubilant Cadista Company Details
Table 84. Jubilant Cadista Business Overview
Table 85. Jubilant Cadista Treatment of Skin Fibrosis Product
Table 86. Jubilant Cadista Revenue in Treatment of Skin Fibrosis Business (2016-2021) & (US$ Million)
Table 87. Jubilant Cadista Recent Development
Table 88. Horizon Pharma USA Company Details
Table 89. Horizon Pharma USA Business Overview
Table 90. Horizon Pharma USA Treatment of Skin Fibrosis Product
Table 91. Horizon Pharma USA Revenue in Treatment of Skin Fibrosis Business (2016-2021) & (US$ Million)
Table 92. Horizon Pharma USA Recent Development
Table 93. Bristol-Myers Squibb Company Company Details
Table 94. Bristol-Myers Squibb Company Business Overview
Table 95. Bristol-Myers Squibb Company Treatment of Skin Fibrosis Product
Table 96. Bristol-Myers Squibb Company Revenue in Treatment of Skin Fibrosis Business (2016-2021) & (US$ Million)
Table 97. Bristol-Myers Squibb Company Recent Development
Table 98. Research Programs/Design for This Report
Table 99. Key Data Information from Secondary Sources
Table 100. Key Data Information from Primary Sources
List of Figures
Figure 1. Global Treatment of Skin Fibrosis Market Share by Type: 2020 VS 2027
Figure 2. Corticosteroids Features
Figure 3. Antifibrotic Drugs Features
Figure 4. Immunotherapy Drugs Features
Figure 5. Other Features
Figure 6. Global Treatment of Skin Fibrosis Market Share by Application: 2020 VS 2027
Figure 7. Hospital Pharmacy Case Studies
Figure 8. Retail Pharmacy Case Studies
Figure 9. Other Case Studies
Figure 10. Treatment of Skin Fibrosis Report Years Considered
Figure 11. Global Treatment of Skin Fibrosis Market Size (US$ Million), Year-over-Year: 2016-2027
Figure 12. Global Treatment of Skin Fibrosis Market Size (US$ Million), 2016 VS 2021 VS 2027
Figure 13. Global Treatment of Skin Fibrosis Market Share by Regions: 2020 VS 2027
Figure 14. Global Treatment of Skin Fibrosis Market Share by Regions (2022-2027)
Figure 15. Global Treatment of Skin Fibrosis Market Share by Players in 2020
Figure 16. Global Top Treatment of Skin Fibrosis Players by Company Type (Tier 1, Tier 2 and Tier 3) (based on the Revenue in Treatment of Skin Fibrosis as of 2020
Figure 17. The Top 10 and 5 Players Market Share by Treatment of Skin Fibrosis Revenue in 2020
Figure 18. Global Treatment of Skin Fibrosis Revenue Market Share by Type (2016-2021)
Figure 19. Global Treatment of Skin Fibrosis Revenue Market Share by Type (2022-2027)
Figure 20. North America Treatment of Skin Fibrosis Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 21. North America Treatment of Skin Fibrosis Market Share by Type (2016-2027)
Figure 22. North America Treatment of Skin Fibrosis Market Share by Application (2016-2027)
Figure 23. North America Treatment of Skin Fibrosis Market Share by Country (2016-2027)
Figure 24. United States Treatment of Skin Fibrosis Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 25. Canada Treatment of Skin Fibrosis Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 26. Europe Treatment of Skin Fibrosis Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 27. Europe Treatment of Skin Fibrosis Market Share by Type (2016-2027)
Figure 28. Europe Treatment of Skin Fibrosis Market Share by Application (2016-2027)
Figure 29. Europe Treatment of Skin Fibrosis Market Share by Country (2016-2027)
Figure 30. Germany Treatment of Skin Fibrosis Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 31. France Treatment of Skin Fibrosis Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 32. U.K. Treatment of Skin Fibrosis Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 33. Italy Treatment of Skin Fibrosis Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 34. Russia Treatment of Skin Fibrosis Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 35. Nordic Treatment of Skin Fibrosis Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 36. Asia-Pacific Treatment of Skin Fibrosis Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 37. Asia-Pacific Treatment of Skin Fibrosis Market Share by Type (2016-2027)
Figure 38. Asia-Pacific Treatment of Skin Fibrosis Market Share by Application (2016-2027)
Figure 39. Asia-Pacific Treatment of Skin Fibrosis Market Share by Region (2016-2027)
Figure 40. China Treatment of Skin Fibrosis Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 41. Japan Treatment of Skin Fibrosis Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 42. South Korea Treatment of Skin Fibrosis Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 43. Southeast Asia Treatment of Skin Fibrosis Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 44. India Treatment of Skin Fibrosis Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 45. Australia Treatment of Skin Fibrosis Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 46. Latin America Treatment of Skin Fibrosis Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 47. Latin America Treatment of Skin Fibrosis Market Share by Type (2016-2027)
Figure 48. Latin America Treatment of Skin Fibrosis Market Share by Application (2016-2027)
Figure 49. Latin America Treatment of Skin Fibrosis Market Share by Country (2016-2027)
Figure 50. Mexico Treatment of Skin Fibrosis Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 51. Brazil Treatment of Skin Fibrosis Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 52. Middle East & Africa Treatment of Skin Fibrosis Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 53. Middle East & Africa Treatment of Skin Fibrosis Market Share by Type (2016-2027)
Figure 54. Middle East & Africa Treatment of Skin Fibrosis Market Share by Application (2016-2027)
Figure 55. Middle East & Africa Treatment of Skin Fibrosis Market Share by Country (2016-2027)
Figure 56. Turkey Treatment of Skin Fibrosis Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 57. Saudi Arabia Treatment of Skin Fibrosis Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 58. UAE Treatment of Skin Fibrosis Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 59. Pfizer Revenue Growth Rate in Treatment of Skin Fibrosis Business (2016-2021)
Figure 60. Sanofi Revenue Growth Rate in Treatment of Skin Fibrosis Business (2016-2021)
Figure 61. F. Hoffmann-La Roche Revenue Growth Rate in Treatment of Skin Fibrosis Business (2016-2021)
Figure 62. Boehringer Ingelheim Revenue Growth Rate in Treatment of Skin Fibrosis Business (2016-2021)
Figure 63. Jubilant Cadista Revenue Growth Rate in Treatment of Skin Fibrosis Business (2016-2021)
Figure 64. Horizon Pharma USA Revenue Growth Rate in Treatment of Skin Fibrosis Business (2016-2021)
Figure 65. Bristol-Myers Squibb Company Revenue Growth Rate in Treatment of Skin Fibrosis Business (2016-2021)
Figure 66. Bottom-up and Top-down Approaches for This Report
Figure 67. Data Triangulation
Figure 68. Key Executives Interviewed
世界の後腹膜線維症治療市場規模・現状・予測（2021年-2027年） Retroperitoneal fibrosis is the rare disease also known as Ormond’s disease. Retroperitoneal fibrosis is characterized by the inflammatory disorder in which abnormal formation of tissue or fibrosis occurs in the back of the abdominal cavity and behind the retro membrane. This area is known as retrop…- 世界の皮膚線維症治療薬市場規模・現状・予測（2021年-2027年） Dermal fibrosis is a fundamental feature of fatty skin sclerosis and is associated with increased levels of the cytokine transforming growth factor-β,186. This growth factor maybe derived from activated leukocytes, recruits macrophages and fibroblasts into the tissue and leads to the production of e…
- 世界の特発性肺線維症治療市場規模・現状・予測（2021年-2027年） Idiopathic Pulmonary Fibrosis Treatment is treatment work on a lung disease which causes the tissue in your lungs to become stiff. Market Analysis and Insights: Global Idiopathic Pulmonary Fibrosis Treatment Market The global Idiopathic Pulmonary Fibrosis Treatment market size is projected to reach…
- 世界の腎臓/腎線維化治療市場規模・現状・予測（2021年-2027年） Kidney/Renal fibrosis, defined as an aberrant wound healing process in response to chronic injury, is characterized by the progressive and persistent accumulation of extracellular matrix components (ECM) in the kidney, ultimately leading to renal failure. Market Analysis and Insights: Global Kidney/…
- 世界の多発性硬化症薬物治療市場規模・現状・予測（2021年-2027年） Multiple sclerosis (MS) is a complex and disabling chronic nervous system disease.This disease acute active central nervous white matter has multiple inflammatory demyelinating spots, old lesions due to glial fiber hyperplasia and calcification spots, with multiple lesions, remission, recurrence of …